FDA Reproductive Cmte. Membership Reflects “Broken Process” – Crawford
Executive Summary
FDA's difficulty in staffing the Reproductive Health Drugs Advisory Committee is a result of a "broken process," Acting Commissioner Lester Crawford told a Women in Government Relations luncheon in Washington, D.C. Oct. 11
You may also be interested in...
IoM Drug Safety Review Will Consider Advisory Committee Process, FDA Says
The Institute of Medicine will consider FDA's use of advisory committees as part of its review of the agency's handling of drug safety issues
IoM Drug Safety Review Will Consider Advisory Committee Process, FDA Says
The Institute of Medicine will consider FDA's use of advisory committees as part of its review of the agency's handling of drug safety issues
FDA “Chief Messaging Officer” Pitts Will Centralize Agency Communications
FDA Associate Commissioner for External Relations Peter Pitts will coordinate FDA's communications within the commissioner's office and across the agency's centers